GO:0098856 intestinal lipid absorption: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098856 intestinal lipid absorption is the biological process by which lipids are taken up from the contents of the intestine.
• Dietary lipids are emulsified, hydrolyzed, and then transported across enterocytes via fatty acid transporters, CD36, and NPC1L1, followed by chylomicron assembly and lymphatic secretion.
• Key genes include CD36, FABP1, MTTP, APOB, NPC1L1, and clock genes such as CLOCK and BMAL1 that regulate lipid uptake.
• Disruption of intestinal lipid absorption contributes to malabsorption, obesity, atherosclerosis, and metabolic disease.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in intestinal lipid absorption.
• Understanding this process informs drug formulation, carotenoid bioavailability, and therapeutic strategies for dyslipidemia.
Description
Intestinal lipid absorption is the biological process by which dietary and biliary lipids are taken up from the intestinal lumen into enterocytes and subsequently transported into the body. This process is essential for energy homeostasis, absorption of fat-soluble vitamins, and the uptake of lipophilic drugs and carotenoids. The Gene Ontology term GO:0098856 captures this process as a defined biological activity, enabling systematic annotation and comparative analysis across species. Researchers study intestinal lipid absorption to understand metabolic disorders, develop oral lipid-based drug delivery systems, and identify therapeutic targets for dyslipidemia and obesity. The process involves coordinated steps including emulsification, hydrolysis, micelle formation, membrane transport, intracellular trafficking, and lipoprotein secretion. Each step is mediated by specific proteins and regulatory pathways that can be interrogated using CRISPR-based models.
intestinal lipid absorption At A Glance
| GO ID | GO:0098856 |
|---|---|
| GO term | intestinal lipid absorption |
| Ontology | biological_process |
| Synonym | none |
| Major function | Uptake of lipids from intestinal contents into enterocytes and subsequent transport |
| Key cellular location | Enterocyte apical membrane, cytoplasm, endoplasmic reticulum, Golgi, basolateral membrane |
| Major transporters | CD36, NPC1L1, FATP4, FABP1 |
| Lipoprotein assembly | MTTP, APOB, chylomicron formation |
| Regulatory factors | Clock genes (CLOCK, BMAL1), PPARs, SREBPs |
What Is GO:0098856?
GO:0098856 intestinal lipid absorption is defined as a process in which lipids are taken up from the contents of the intestine. This encompasses the initial digestion and solubilization of dietary fats, their transport across the apical membrane of enterocytes, intracellular processing, and eventual secretion into lymph or portal circulation. The term is a biological process in the Gene Ontology and is distinct from systemic lipid transport or intracellular lipid metabolism.
Why Is intestinal lipid absorption Important in Cell Biology?
Intestinal lipid absorption is a central physiological process that determines systemic lipid availability and energy balance. Its dysregulation is linked to obesity, atherosclerosis, type 2 diabetes, and malabsorption syndromes. Moreover, many orally administered lipophilic drugs rely on intestinal lipid absorption pathways for bioavailability, making this process a key consideration in pharmaceutical development. Understanding the molecular players and regulatory mechanisms is therefore critical for both basic biology and translational medicine.
• Maintains energy homeostasis by absorbing dietary fats and fat-soluble vitamins.
• Dysregulation contributes to obesity, insulin resistance, and cardiovascular disease.
• Impaired absorption causes malabsorption and steatorrhea after intestinal resection.
• Influences bioavailability of lipophilic drugs and carotenoids.
• Regulated by circadian clock genes, linking timing of food intake to lipid handling.
• Provides targets for anti-obesity and lipid-lowering therapies.
• Involved in chylomicron assembly and secretion, affecting postprandial lipemia.
• Key for understanding intestinal adaptation after bariatric surgery or resection.
• Relevant to pediatric development and neonatal nutrition.
• Serves as a model for studying membrane transport and lipoprotein biology.
What Happens During intestinal lipid absorption?
Luminal digestion and micelle formation
In simple terms: Fats are broken down and packaged into tiny bubbles so they can approach the gut lining.
Dietary triglycerides are emulsified by bile salts and hydrolyzed by pancreatic lipase into free fatty acids and monoglycerides. These products, along with cholesterol and phospholipids, form mixed micelles that ferry lipids to the enterocyte brush border. This step is essential for efficient uptake and is influenced by the composition of the intestinal contents.
Apical membrane transport
In simple terms: Lipids cross the outer membrane of intestinal cells through specialized doorways.
Free fatty acids and cholesterol are taken up across the apical membrane via transporters such as CD36, NPC1L1, and FATP4. CD36 facilitates fatty acid uptake, while NPC1L1 mediates cholesterol absorption. These transporters are regulated by dietary and hormonal signals, and their expression levels correlate with absorption efficiency.
Intracellular trafficking and processing
In simple terms: Once inside, lipids are shuttled to different parts of the cell for processing.
Inside enterocytes, fatty acids are bound by FABP1 and directed to the endoplasmic reticulum for re-esterification into triglycerides and phospholipids. Cholesterol is esterified by ACAT2. These lipids are then assembled into lipoproteins. This intracellular phase involves multiple enzymes and binding proteins that determine the fate of absorbed lipids.
Chylomicron assembly and secretion
In simple terms: Lipids are packaged into carriers that are released into the lymph for distribution.
In the endoplasmic reticulum, MTTP lipidates APOB to form nascent chylomicrons. These particles are transported through the Golgi and secreted into the lymphatic system via the basolateral membrane. This step is rate-limiting for overall lipid absorption and is regulated by factors such as clock genes and nutrient status.
Regulation by clock genes and nuclear receptors
In simple terms: The body's internal clock and nutrient sensors adjust how much fat is absorbed.
Circadian clock genes such as CLOCK and BMAL1 regulate the expression of intestinal lipid transporters and apolipoproteins, influencing the timing of lipid absorption. Nuclear receptors including PPARs and SREBPs also modulate genes involved in lipid uptake and lipoprotein secretion. This regulation ensures that lipid absorption aligns with feeding rhythms and metabolic demands.
Key Genes Involved in GO:0098856 intestinal lipid absorption
The following genes encode proteins with well-documented roles in intestinal lipid absorption, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD36 | Fatty acid transport across apical membrane | Knockout reduces fatty acid uptake; target for obesity studies |
| NPC1L1 | Cholesterol uptake | Target of ezetimibe; knockout lowers cholesterol absorption |
| FABP1 | Intracellular fatty acid binding and trafficking | Knockout alters lipid processing and chylomicron secretion |
| MTTP | Lipid transfer for APOB lipidation | Mutations cause abetalipoproteinemia; essential for chylomicron assembly |
| APOB | Structural apolipoprotein of chylomicrons | Knockout prevents chylomicron formation; used in lipoprotein research |
| FATP4 | Fatty acid transport | Knockout impairs lipid uptake; linked to skin and intestinal defects |
| CLOCK | Circadian regulation of lipid transporters | Knockout disrupts diurnal lipid absorption |
| BMAL1 | Core clock transcription factor | Regulates expression of CD36 and APOB |
| PPARA | Nuclear receptor regulating lipid metabolism | Knockout alters intestinal lipid handling |
| SREBF1 | Lipogenic transcription factor | Overexpression increases lipid uptake and storage |
| ACAT2 | Cholesterol esterification | Knockout reduces cholesterol absorption |
| SAR1B | ER-to-Golgi transport of chylomicrons | Mutations cause chylomicron retention disease |
| LPL | Lipoprotein lipase for triglyceride hydrolysis | Knockout affects postprandial lipid clearance |
| ANGPTL4 | Inhibitor of LPL | Overexpression reduces lipid uptake; target for dyslipidemia |
| NR1H2 | LXR beta, regulates cholesterol absorption | Knockout alters NPC1L1 expression |
| HNF4A | Transcription factor for enterocyte differentiation | Knockout impairs lipid absorption gene expression |
How Is intestinal lipid absorption Regulated?
Intestinal lipid absorption is regulated at multiple levels. Circadian clock genes CLOCK and BMAL1 control diurnal expression of CD36, FABP1, and APOB, thereby modulating the timing of lipid uptake. Nuclear receptors PPARs and LXRs respond to dietary lipids and regulate transporter genes. Hormones such as GLP-1 and PYY influence intestinal motility and lipid handling. Additionally, the mTOR pathway integrates nutrient signals to control enterocyte growth and lipid processing. These regulatory layers ensure that lipid absorption adapts to feeding status and metabolic needs.
intestinal lipid absorption and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTTP | Abetalipoproteinemia | Knockout in Caco-2 cells or mouse intestine |
| SAR1B | Chylomicron retention disease | Point mutation knock-in in enterocytes |
| CD36 | Obesity and insulin resistance | Intestinal-specific knockout mouse |
| NPC1L1 | Hypercholesterolemia | Knockout and overexpression in enterocyte lines |
| CLOCK | Circadian disruption and metabolic syndrome | Knockout mouse with timed lipid challenge |
Malabsorption and intestinal resection
Partial small bowel resection impairs overall intestinal lymphatic transport and lipid absorption, leading to steatorrhea and malnutrition. This condition highlights the importance of intact absorptive surface and lymphatic drainage for lipid uptake.
Obesity and metabolic syndrome
Excessive intestinal lipid absorption contributes to obesity, insulin resistance, and dyslipidemia. Targeting transporters such as CD36 or NPC1L1 is a therapeutic strategy to reduce lipid uptake.
Atherosclerosis and cardiovascular disease
Increased chylomicron secretion and postprandial lipemia are risk factors for atherosclerosis. Genes involved in chylomicron assembly, such as MTTP and APOB, are linked to cardiovascular risk.
Abetalipoproteinemia and chylomicron retention disease
Mutations in MTTP cause abetalipoproteinemia, characterized by defective chylomicron assembly and fat malabsorption. SAR1B mutations cause chylomicron retention disease, further demonstrating the importance of intracellular transport in lipid absorption.
From intestinal lipid absorption-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate fatty acid uptake? | CRISPR knockout in Caco-2 or primary enterocytes |
| Does a point mutation in gene Y affect chylomicron secretion? | Point mutation knock-in in mouse intestinal organoids |
| Can overexpression of gene Z enhance lipid absorption? | Transgenic overexpression in zebrafish or mouse |
| Where is protein X localized during lipid absorption? | Tagged knock-in with fluorescent reporter |
| Does gene W affect circadian lipid absorption? | Knockout mouse with time-restricted feeding |
| Can CRISPR library screening identify new lipid absorption genes? | Pooled CRISPR screen in enterocyte cell line |
How to Study the intestinal lipid absorption Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Oral fat tolerance test | Postprandial triglyceride levels | Assessing lipid absorption in mice |
| Lymphatic cannulation | Chylomicron secretion rate | Quantifying intestinal lipid transport |
| Caco-2 transport assay | Apical to basolateral lipid flux | Screening transporters and inhibitors |
| RNA-seq | Gene expression changes | Identifying regulated pathways |
| Proteomics | Protein abundance and modifications | Discovering new players in lipid absorption |
| Organoid imaging | Lipid droplet and chylomicron dynamics | Studying intracellular trafficking |
| CRISPR screen | Gene essentiality for lipid uptake | Unbiased discovery of novel regulators |
In vivo lipid absorption assays
Oral fat tolerance tests and lymphatic cannulation in mice measure the rate and extent of lipid absorption and chylomicron secretion. These methods provide physiological relevance and can be combined with genetic models.
Cell-based transport assays
Caco-2 cell monolayers are used to study apical uptake and basolateral secretion of fluorescently labeled fatty acids or cholesterol. Transport inhibitors and gene knockdown/knockout can dissect specific pathways.
Transcriptomics and proteomics
RNA-seq and proteomics of intestinal tissue or enterocytes reveal changes in expression of lipid transporters and lipoprotein assembly genes under different conditions. These approaches identify regulatory networks and candidate genes.
Imaging and organoids
Intestinal organoids and live-cell imaging allow visualization of lipid droplet formation, chylomicron trafficking, and transporter localization. These models bridge in vitro and in vivo studies.
How CRISPR Can Be Used to Study GO:0098856 intestinal lipid absorption
Knockout
CRISPR knockout of candidate genes such as CD36 or NPC1L1 in enterocyte cell lines or mouse models abolishes specific lipid uptake pathways, providing causal evidence for their role in intestinal lipid absorption.
Point Mutation
Introducing disease-associated point mutations (e.g., in MTTP or SAR1B) via CRISPR base editing or homology-directed repair recapitulates functional defects in chylomicron assembly and secretion, linking genotype to phenotype.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci (e.g., APOB or FABP1) enables real-time tracking of protein localization and dynamics during lipid absorption.
Overexpression
CRISPR activation or transgenic overexpression of genes such as ANGPTL4 or SREBF1 can enhance or suppress lipid absorption, allowing gain-of-function studies in relevant models.
How EDITGENE Supports intestinal lipid absorption Research
Researchers studying intestinal lipid absorption-related genes often need to determine whether a candidate gene is causally involved in lipid uptake, transport, or lipoprotein secretion. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for intestinal lipid absorption research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| UGCG Knockout HEK293 Cell Line | EDJ-KQ2506 | Human | 7357 | Details Get a Quote |
| FABP2 Knockout HEK293 Cell Line | EDJ-KQ3670 | Human | 2169 | Details Get a Quote |
| UGCG Knockout A-549 Cell Line | EDJ-KQ23102 | Human | 7357 | Details Get a Quote |
| UGCG Knockout HCT 116 Cell Line | EDJ-KQ23103 | Human | 7357 | Details Get a Quote |
| UGCG Knockout HeLa Cell Line | EDJ-KQ23104 | Human | 7357 | Details Get a Quote |
| FABP2 Knockout HeLa Cell Line | EDJ-KQ53197 | Human | 2169 | Details Get a Quote |
| FABP2 Knockout A-549 Cell Line | EDJ-KQ61675 | Human | 2169 | Details Get a Quote |
| FABP2 Knockout HCT 116 Cell Line | EDJ-KQ70158 | Human | 2169 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records
Frequently Asked Questions About intestinal lipid absorption
What is GO:0098856 intestinal lipid absorption?
GO:0098856 is a Gene Ontology biological process term defined as the process in which lipids are taken up from the contents of the intestine.
What genes are involved in intestinal lipid absorption?
Key genes include CD36, NPC1L1, FABP1, MTTP, APOB, and clock genes such as CLOCK and BMAL1.
How is intestinal lipid absorption regulated?
It is regulated by circadian clock genes, nuclear receptors, and nutrient-sensing pathways such as mTOR.
What diseases are associated with defective intestinal lipid absorption?
Malabsorption, abetalipoproteinemia, chylomicron retention disease, obesity, and atherosclerosis.
What methods are used to study intestinal lipid absorption?
Oral fat tolerance tests, lymphatic cannulation, Caco-2 transport assays, RNA-seq, proteomics, and organoid imaging.
Can CRISPR be used to study intestinal lipid absorption?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this process.
What is the role of CD36 in intestinal lipid absorption?
CD36 facilitates fatty acid uptake across the apical membrane of enterocytes.
How do clock genes affect lipid absorption?
CLOCK and BMAL1 regulate diurnal expression of lipid transporters and apolipoproteins, influencing the timing of absorption.
What is chylomicron assembly?
Chylomicron assembly is the packaging of lipids with APOB and MTTP in the endoplasmic reticulum for secretion into lymph.
Why is intestinal lipid absorption important for drug delivery?
Many lipophilic drugs rely on lipid absorption pathways for oral bioavailability, making this process relevant to formulation science.
Conclusion
GO:0098856 intestinal lipid absorption is a fundamental biological process with broad implications for metabolism, disease, and pharmacology. The coordinated action of transporters, binding proteins, and lipoprotein assembly factors ensures efficient uptake of dietary lipids. CRISPR-based models are powerful tools to dissect the causal roles of these genes. EDITGENE offers comprehensive services to support such research, from knockout to library screening.
References
- 1. Ko CW et al.. 2020. Regulation of intestinal lipid metabolism: current concepts and relevance to disease.. Nat Rev Gastroenterol Hepatol 17(3):169-183 PMID: 32015520
- 2. Phan CT et al.. 2001. Intestinal lipid absorption and transport.. Front Biosci 6:D299-319 PMID: 11229876
- 3. Green PH et al.. 1981. Lipid absorption and intestinal lipoprotein formation.. Aust N Z J Med 11(1):84-90 PMID: 7018485
- 4. Guo Z et al.. 2024. Mechanisms of carotenoid intestinal absorption and the regulation of dietary lipids: lipid transporter-mediated transintestinal epithelial pathways.. Crit Rev Food Sci Nutr 64(7):1791-1816 PMID: 36069234
- 5. Hussain MM. 2014. Regulation of intestinal lipid absorption by clock genes.. Annu Rev Nutr 34:357-75 PMID: 25033063
- 6. Onufer EJ et al.. 2022. Lipid absorption and overall intestinal lymphatic transport are impaired following partial small bowel resection in mice.. Sci Rep 12(1):11527 PMID: 35798817
- 7. Constantinides PP et al.. 2007. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies.. J Pharm Sci 96(2):235-48 PMID: 17051593
- 8. Black DD. 2007. Development and physiological regulation of intestinal lipid absorption. I. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion.. Am J Physiol Gastrointest Liver Physiol 293(3):G519-24 PMID: 17495031
